199 related articles for article (PubMed ID: 25253971)
21. Complete pathological response (ypT0N0M0) after preoperative chemotherapy alone for stage IV rectal cancer.
Naiken SP; Toso C; Rubbia-Brandt L; Thomopoulos T; Roth A; Mentha G; Morel P; Gervaz P
BMC Surg; 2014 Jan; 14():4. PubMed ID: 24438090
[TBL] [Abstract][Full Text] [Related]
22. Bevacizumab plus FOLFIRI or FOLFOX as third-line or later treatment in patients with metastatic colorectal cancer after failure of 5-fluorouracil, irinotecan, and oxaliplatin: a retrospective analysis.
Kang BW; Kim TW; Lee JL; Ryu MH; Chang HM; Yu CS; Kim JC; Kim JH; Kang YK; Lee JS
Med Oncol; 2009; 26(1):32-7. PubMed ID: 18498064
[TBL] [Abstract][Full Text] [Related]
23. Non-α-fetoprotein-producing adrenal hepatoid adenocarcinoma: A case report and literature review.
Lin J; Cao Y; Yu L; Lin L
Medicine (Baltimore); 2018 Sep; 97(39):e12336. PubMed ID: 30278510
[TBL] [Abstract][Full Text] [Related]
24. An effective 5-fluorouracil, levofolinate, and oxaliplatin therapy for recurrent breast cancer: a case report.
Takahashi M; Niwa K; Ishiyama S; Sugimoto K; Komiyama H; Yaginuma Y; Kojima Y; Goto M; Okuzawa A; Tomiki Y; Sakamoto K
J Med Case Rep; 2014 Jun; 8():234. PubMed ID: 24969166
[TBL] [Abstract][Full Text] [Related]
25. Leucovorin, fluorouracil, and oxaliplatin plus bevacizumab versus S-1 and oxaliplatin plus bevacizumab in patients with metastatic colorectal cancer (SOFT): an open-label, non-inferiority, randomised phase 3 trial.
Yamada Y; Takahari D; Matsumoto H; Baba H; Nakamura M; Yoshida K; Yoshida M; Iwamoto S; Shimada K; Komatsu Y; Sasaki Y; Satoh T; Takahashi K; Mishima H; Muro K; Watanabe M; Sakata Y; Morita S; Shimada Y; Sugihara K
Lancet Oncol; 2013 Dec; 14(13):1278-86. PubMed ID: 24225157
[TBL] [Abstract][Full Text] [Related]
26. Prospective randomized trial evaluating mandatory second look surgery with HIPEC and CRS vs. standard of care in patients at high risk of developing colorectal peritoneal metastases.
Ripley RT; Davis JL; Kemp CD; Steinberg SM; Toomey MA; Avital I
Trials; 2010 May; 11():62. PubMed ID: 20500867
[TBL] [Abstract][Full Text] [Related]
27. Oxaliplatin-related acute myelogenous leukemia.
Carneiro BA; Kaminer L; Eldibany M; Sreekantaiah C; Kaul K; Locker GY
Oncologist; 2006 Mar; 11(3):261-2. PubMed ID: 16549810
[TBL] [Abstract][Full Text] [Related]
28. Colonic cancer in a patient with primary sclerosing cholangitis and long-standing ulcerative colitis.
Seo M; Okada M; Osamura S; Hara S; Umeno T; Maeshiro K; Yamada Y; Yuh K
J Gastroenterol; 1997 Feb; 32(1):83-8. PubMed ID: 9058300
[TBL] [Abstract][Full Text] [Related]
29. Neoadjuvant bevacizumab and chemoradiotherapy in locally advanced rectal cancer: early outcome and technical impact on toxicity.
Wang CC; Liang JT; Tsai CL; Chen YH; Lin YL; Shun CT; Cheng JC
World J Surg Oncol; 2014 Nov; 12():329. PubMed ID: 25373828
[TBL] [Abstract][Full Text] [Related]
30. [Effective chemotherapy with bevacizumab/FOLFOX4 for neuroendocrine carcinoma of the ascending colon - a case study].
Tanabe H; Takase T; Morimoto D; Tanaka Y; Shibata A; Yaguchi T
Gan To Kagaku Ryoho; 2014 May; 41(5):661-4. PubMed ID: 24917018
[TBL] [Abstract][Full Text] [Related]
31. Partial response after transcatheter arterial infusion chemotherapy in a patient with systemic chemotherapy-resistant unresectable colon cancer and hepatic metastasis: (case report).
Sawai K; Goi T; Koneri K; Katayama K; Yamaguchi A
World J Surg Oncol; 2013 Aug; 11(1):203. PubMed ID: 23957924
[TBL] [Abstract][Full Text] [Related]
32. Bevacizumab in stage II-III colon cancer: 5-year update of the National Surgical Adjuvant Breast and Bowel Project C-08 trial.
Allegra CJ; Yothers G; O'Connell MJ; Sharif S; Petrelli NJ; Lopa SH; Wolmark N
J Clin Oncol; 2013 Jan; 31(3):359-64. PubMed ID: 23233715
[TBL] [Abstract][Full Text] [Related]
33. The effect of DNA mismatch repair (MMR) status on oxaliplatin-based first-line chemotherapy as in recurrent or metastatic colon cancer.
Kim ST; Lee J; Park SH; Park JO; Lim HY; Kang WK; Kim JY; Kim YH; Chang DK; Rhee PL; Kim DS; Yun H; Cho YB; Kim HC; Yun SH; Chun HK; Lee WY; Park YS
Med Oncol; 2010 Dec; 27(4):1277-85. PubMed ID: 19949897
[TBL] [Abstract][Full Text] [Related]
34. Scan? Cure? Sure!
Goldberg RM; Ryan DP
Oncologist; 2011; 16(2):254-6. PubMed ID: 21349952
[TBL] [Abstract][Full Text] [Related]
35. Synchronous colonic adenocarcinoma and pelvic schwannoma.
Bai J; Kleyser-Sugrue K; Nerenstone SR; Welch JP
Conn Med; 2011 Feb; 75(2):93-5. PubMed ID: 21476379
[TBL] [Abstract][Full Text] [Related]
36. Initial safety report of NSABP C-08: A randomized phase III study of modified FOLFOX6 with or without bevacizumab for the adjuvant treatment of patients with stage II or III colon cancer.
Allegra CJ; Yothers G; O'Connell MJ; Sharif S; Colangelo LH; Lopa SH; Petrelli NJ; Goldberg RM; Atkins JN; Seay TE; Fehrenbacher L; O'Reilly S; Chu L; Azar CA; Wolmark N
J Clin Oncol; 2009 Jul; 27(20):3385-90. PubMed ID: 19414665
[TBL] [Abstract][Full Text] [Related]
37. Double primary adenocarcinomas of the jejunum and descending colon with lung metastases presenting rare immunohistochemical phenotypes: a case report.
Nozawa H; Yamada Y; Muto Y; Endo J; Asakage M; Oka T; Furukawa Y; Arai M
Eur J Gastroenterol Hepatol; 2010 Feb; 22(2):228-33. PubMed ID: 19923997
[TBL] [Abstract][Full Text] [Related]
38. [Acute "pseudo-angiocholitis" due to colonic adenocarcinoma in a man with primary sclerosis cholangitis and ulcerative colitis].
Coatmeur O; Rassiat E; Bonniaud P; Jouve JL; Minello A; Bedenne L; Faivre J; Hillon P
Ann Med Interne (Paris); 2003 Dec; 154(8):547-8. PubMed ID: 15037832
[TBL] [Abstract][Full Text] [Related]
39. Hepatoid adenocarcinoma of the stomach: an unusual case of elevated alpha-fetoprotein with prior treatment for hepatocellular carcinoma.
Ahn JS; Jeon JR; Yoo HS; Park TK; Park CK; Sinn DH; Paik SW
Clin Mol Hepatol; 2013 Jun; 19(2):173-8. PubMed ID: 23837142
[TBL] [Abstract][Full Text] [Related]
40. Oxaliplatin-associated sarcoid-like reaction masquerading as recurrent colon cancer.
Aedma SK; Chidharla A; Kelting S; Kasi A
BMJ Case Rep; 2020 Sep; 13(9):. PubMed ID: 32907862
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
